We are painfully aware of the global nature of the COVID-19 pandemic.
We are fielding multiple requests from representatives of health ministries, who would like to access RLF-100 for their countries.
At this point in time, NeuroRx does not have the bandwidth to enter into the traditional drug approval process outside the United States. We are, however, prepared to partner with emergency use programs with Health Ministry approval.